Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 61 articles: HTML format

Single Articles

March 2024
1. SAIKIA J, Malik PS, Kumar S, Jain D, et al
   Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study.
   J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27610.
   PubMed     Abstract available
   
   
   January 2024
2. PEZESHKIAN F, McAllister M, Singh A, Theeuwen H, et al
   What's new in thoracic oncology.
   J Surg Oncol. 2024;129:128-137.
   PubMed     Abstract available
   
   
   December 2023
3. GUPTA S, Wells SL, Jose AM, Seitter RH, et al
   High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.
   J Surg Oncol. 2023;128:1141-1149.
   PubMed     Abstract available
   
   
   October 2023
4. DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al
   Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
   J Surg Oncol. 2023 Oct 24. doi: 10.1002/jso.27490.
   PubMed     Abstract available
   
   
   September 2023
5. DEBAN M, Taqi K, Knapp GC, Soucisse M, et al
   Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma: Canadian practices and outcomes.
   J Surg Oncol. 2023;128:595-603.
   PubMed     Abstract available
   
   
   
6. NIE K, Tao G, Zhu L, Zhang Y, et al
   Clinicopathological features and survival of rare primary pulmonary lymphoepithelial carcinoma: A cohort from a single center.
   J Surg Oncol. 2023;128:675-681.
   PubMed     Abstract available
   
   
   July 2023
7. VAN DORP M, Unal S, Gooijer S, Dickhoff C, et al
   Salvage surgery for local recurrences after stereotactic ablative radiotherapy of colorectal pulmonary metastases.
   J Surg Oncol. 2023 Jul 21. doi: 10.1002/jso.27404.
   PubMed     Abstract available
   
   
   
8. MURAOKA Y, Yotsukura M, Yoshida Y, Nakagawa K, et al
   Dynamics of recurrence after curative resection of nonsmall cell lung cancer.
   J Surg Oncol. 2023 Jul 17. doi: 10.1002/jso.27395.
   PubMed     Abstract available
   
   
   
9. DE BARROS MLGP, Silva VG, Moreira FR, Perez SV, et al
   Five-year survival of resectable stage IIIA non-small cell lung cancer in Brazil.
   J Surg Oncol. 2023 Jul 13. doi: 10.1002/jso.27394.
   PubMed     Abstract available
   
   
   
10. MATSUURA Y, Mun M, Shintani Y, Okami J, et al
    Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database.
    J Surg Oncol. 2023 Jul 5. doi: 10.1002/jso.27384.
    PubMed     Abstract available
    
    
    
11. TAIOLI E, Wolf A, Alpert N, Rosenthal D, et al
    Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
    J Surg Oncol. 2023;128:134-141.
    PubMed     Abstract available
    
    
    June 2023
12. UDELSMAN BV, Blasberg J
    Expanding the scope of preoperative localization.
    J Surg Oncol. 2023;127:1225.
    PubMed    
    
    
    
13. GALLINA FT, Cappelli F, Forcella D, Taje R, et al
    CT-guided indocyanine green and lipiodol marking of ground glass opacity before robotic-assisted lung resection.
    J Surg Oncol. 2023;127:1223-1224.
    PubMed    
    
    
    May 2023
14. HONG Z, Cui B, Sheng Y, Lu Y, et al
    Effects of da Vinci robot versus thoracoscopic surgery on body trauma and lymphocyte subsets in lung cancer patients: A propensity score matching study.
    J Surg Oncol. 2023 May 12. doi: 10.1002/jso.27312.
    PubMed     Abstract available
    
    
    
15. GALLINA FT, Melis E, Bertolaccini L, Spaggiari L, et al
    A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomy.
    J Surg Oncol. 2023;127:1035-1042.
    PubMed     Abstract available
    
    
    April 2023
16. HANSDOTTER P, Scherman P, Nikberg M, Petersen SH, et al
    Treatment and survival of patients with metachronous colorectal lung metastases.
    J Surg Oncol. 2023;127:806-814.
    PubMed     Abstract available
    
    
    March 2023
17. TREASURE T, Macbeth F
    Finding that outcomes after imaging-guided thermal ablation and surgery for colorectal lung metastases are similar does not prove a survival benefit from either.
    J Surg Oncol. 2023;127:510-512.
    PubMed    
    
    
    February 2023
18. KADER S, Watkins A, Servais EL
    The oncologic efficacy of extended thoracic resections.
    J Surg Oncol. 2023;127:288-295.
    PubMed     Abstract available
    
    
    
19. NASO J, Lo YC, Sholl LM
    Updates in pathology and molecular diagnostics to inform the evolving landscape of thoracic surgery and oncology.
    J Surg Oncol. 2023;127:244-257.
    PubMed     Abstract available
    
    
    
20. ETIENNE H, Kalt F, Park S, Opitz I, et al
    The oncologic efficacy of extended resections for lung cancer.
    J Surg Oncol. 2023;127:296-307.
    PubMed     Abstract available
    
    
    
21. PAAJANEN J, Jaklitsch MT, Bueno R
    Contemporary issues in the surgical management of pleural mesothelioma.
    J Surg Oncol. 2023;127:343-354.
    PubMed     Abstract available
    
    
    
22. SWANSON SJ, White A
    Sublobar resections for lung cancer: Finally, some answers and some more questions?
    J Surg Oncol. 2023;127:269-274.
    PubMed     Abstract available
    
    
    
23. EISENBERG M, Deboever N, Antonoff MB
    Salvage surgery in lung cancer following definitive therapies.
    J Surg Oncol. 2023;127:319-328.
    PubMed     Abstract available
    
    
    
24. DEBOEVER N, Eisenberg M, Chidi A, Sepesi B, et al
    The role of immunotherapy and targeted therapy in the multimodal therapy for resectable lung cancer.
    J Surg Oncol. 2023;127:275-281.
    PubMed     Abstract available
    
    
    
25. SINGH A, Jaklitsch MT
    Lymph node sampling-what are the numbers?
    J Surg Oncol. 2023;127:308-318.
    PubMed     Abstract available
    
    
    
26. FREYALDENHOVEN ST, Tsukada H
    Robotics in the diagnosis and staging of lung cancer.
    J Surg Oncol. 2023;127:258-261.
    PubMed     Abstract available
    
    
    
27. UDELSMAN BV, Blasberg JD
    Using the robotic platform in the therapy of multifocal ground glass opacities.
    J Surg Oncol. 2023;127:262-268.
    PubMed     Abstract available
    
    
    January 2023
28. HONG JH, Swami N, Dee EC, Gomez SL, et al
    Non-small cell lung cancer disparities in stage at presentation and treatment for Asian American, Native Hawaiian, and Pacific Islander women.
    J Surg Oncol. 2023 Jan 31. doi: 10.1002/jso.27204.
    PubMed     Abstract available
    
    
    
29. YANAGAWA N, Sugai M, Shikanai S, Sugimoto R, et al
    The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
    J Surg Oncol. 2023;127:174-182.
    PubMed     Abstract available
    
    
    December 2022
30. NA KJ, Kim YT
    The "new" oligometastatic disease state and associated therapies in non-small cell lung cancer: A narrative review.
    J Surg Oncol. 2022 Dec 5. doi: 10.1002/jso.27165.
    PubMed     Abstract available
    
    
    
31. ZHOU L, Zhou Z, Liu F, Sun H, et al
    Establishment and validation of a clinical model for diagnosing solitary pulmonary nodules.
    J Surg Oncol. 2022;126:1316-1329.
    PubMed     Abstract available
    
    
    
32. WOLF A, Laskey D, Yip R, Beasley MB, et al
    Measuring the margin distance in pulmonary wedge resection.
    J Surg Oncol. 2022;126:1350-1358.
    PubMed     Abstract available
    
    
    
33. LIU F, Dai L, Wang Y, Liu M, et al
    Derivation and validation of a prediction model for patients with lung nodules malignancy regardless of mediastinal/hilar lymphadenopathy.
    J Surg Oncol. 2022;126:1551-1559.
    PubMed     Abstract available
    
    
    November 2022
34. KARAM E, Tabutin M, Dupre A
    Neither surveillance nor treatment showed significant survival benefit for lung metastases from colorectal cancer, imaging guided thermal ablation is a safe and efficient alternative to surgery.
    J Surg Oncol. 2022 Nov 17. doi: 10.1002/jso.27148.
    PubMed    
    
    
    
35. ABRAO FC, de Abreu IRLB, Silva VG, Rosamilia GA, et al
    Overall survival and prognostic factors in Stage I lung adenocarcinoma treated with curative intent: A real-life 19-year cohort study.
    J Surg Oncol. 2022;126:1114-1122.
    PubMed     Abstract available
    
    
    
36. ZHAI R, Liu H, Wang J, Shan L, et al
    Extensive open lobectomy experience is not a prerequisite for learning uniportal video-assisted thoracic surgery lobectomy.
    J Surg Oncol. 2022;126:1104-1113.
    PubMed     Abstract available
    
    
    October 2022
37. RUSCH VW
    Five decades of progress in surgical oncology: Tumors of the lung and esophagus.
    J Surg Oncol. 2022;126:921-925.
    PubMed     Abstract available
    
    
    September 2022
38. KARAM E, Tabutin M, Mastier C, Crignis L, et al
    Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
    J Surg Oncol. 2022 Sep 28. doi: 10.1002/jso.27108.
    PubMed     Abstract available
    
    
    
39. LOGAN CD, Feinglass J, Halverson AL, Lung K, et al
    Rural-urban survival disparities for patients with surgically treated lung cancer.
    J Surg Oncol. 2022 Sep 17. doi: 10.1002/jso.27045.
    PubMed     Abstract available
    
    
    
40. MITZMAN B, Wang X, Haaland B, Varghese TK Jr, et al
    Trends and factors affecting approach choice to pulmonary resection.
    J Surg Oncol. 2022;126:599-608.
    PubMed     Abstract available
    
    
    
41. CHIAPPETTA M, Lococo F, Sperduti I, Cusumano G, et al
    Lymphadenectomy for lung carcinoids: Which factors may predict nodal upstaging? A multi centric, retrospective study.
    J Surg Oncol. 2022;126:588-598.
    PubMed     Abstract available
    
    
    August 2022
42. NAKAHASHI K, Shiono S, Nakatsuka M, Endo M, et al
    Prognostic impact of the tumor volume doubling time in clinical T1 non-small cell lung cancer with solid radiological findings.
    J Surg Oncol. 2022 Aug 3. doi: 10.1002/jso.27043.
    PubMed     Abstract available
    
    
    
43. KODIKARA H, Wanaguru D, Karpelowsky J, Singh H, et al
    Systemic indocyanine green localization with thoracoscopic thermal sealing and suture: A useful method for subpleural pulmonary osteosarcoma metastectomy.
    J Surg Oncol. 2022;126:383-385.
    PubMed    
    
    
    May 2022
44. DOLAN DP, Lee DN, Kucukak S, De Leon LE, et al
    Salvage surgery for local recurrence after sublobar surgery in Stages I and II non-small cell lung cancer.
    J Surg Oncol. 2022 May 23. doi: 10.1002/jso.26925.
    PubMed     Abstract available
    
    
    April 2022
45. TETEH DK, Barajas J, Ferrell B, Zhou Z, et al
    The impact of the COVID-19 pandemic on care delivery and quality of life in lung cancer surgery.
    J Surg Oncol. 2022 Apr 23. doi: 10.1002/jso.26902.
    PubMed     Abstract available
    
    
    
46. HUANG S, Parekh V, Waisman J, Jones V, et al
    Cutaneous metastasectomy: Is there a role in breast cancer? A systematic review and overview of current treatment modalities.
    J Surg Oncol. 2022 Apr 7. doi: 10.1002/jso.26870.
    PubMed     Abstract available
    
    
    March 2022
47. COOPER L, Gong Y, Dezube AR, Mazzola E, et al
    Thoracic surgery with geriatric assessment and collaboration can prepare frail older adults for lung cancer surgery.
    J Surg Oncol. 2022 Mar 25. doi: 10.1002/jso.26866.
    PubMed     Abstract available
    
    
    
48. CONGEDO MT, Nachira D, Bertolaccini L, Chiappetta M, et al
    Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery.
    J Surg Oncol. 2022;125:782-789.
    PubMed     Abstract available
    
    
    
49. HUANG W, Zhang H, Zhang Z, Zhang B, et al
    A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma.
    J Surg Oncol. 2022;125:796-808.
    PubMed     Abstract available
    
    
    February 2022
50. KAO CN, Liu YW
    Simultaneous bilateral pulmonary metastasectomy: A cost-effective surgery.
    J Surg Oncol. 2022;125:310-311.
    PubMed    
    
    
    January 2022
51. LOHINAI Z, Dora D, Caldwell C, Rivard CJ, et al
    Loss of STING expression is prognostic in non-small cell lung cancer.
    J Surg Oncol. 2022 Jan 31. doi: 10.1002/jso.26804.
    PubMed     Abstract available
    
    
    
52. DEZUBE AR, Mazzola E, Cooper L, Deeb AL, et al
    Geographic differences in therapy for stage I non-small-cell lung cancer in older adults.
    J Surg Oncol. 2022 Jan 31. doi: 10.1002/jso.26809.
    PubMed     Abstract available
    
    
    
53. REN Y, She Y, Tang H, Deng J, et al
    Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population.
    J Surg Oncol. 2022 Jan 31. doi: 10.1002/jso.26810.
    PubMed     Abstract available
    
    
    
54. KE L, Cui S, Yang M, Chen J, et al
    Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross-sectional observational study.
    J Surg Oncol. 2022 Jan 18. doi: 10.1002/jso.26794.
    PubMed     Abstract available
    
    
    December 2021
55. KIM JC, Ha YJ, Park IJ, Kim CW, et al
    Tumor immune microenvironment of primary colorectal adenocarcinomas metastasizing to the liver or lungs.
    J Surg Oncol. 2021;124:1136-1145.
    PubMed     Abstract available
    
    
    
56. LEE RM, Ethun CG, Gamboa AC, Turgeon MK, et al
    A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative.
    J Surg Oncol. 2021;124:1477-1484.
    PubMed     Abstract available
    
    
    September 2021
57. SMITH A, Wali A, Montes A, Hadaki M, et al
    Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.
    J Surg Oncol. 2021 Sep 27. doi: 10.1002/jso.26691.
    PubMed     Abstract available
    
    
    
58. CORSINI EM, Mitchell KG, Zhou N, Bernatchez C, et al
    Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
    J Surg Oncol. 2021;124:699-703.
    PubMed     Abstract available
    
    
    
59. LI S, Wu J, Wan Z, Chen Y, et al
    The learning curve for uniportal video-assisted thoracoscopic anatomical segmentectomy.
    J Surg Oncol. 2021;124:441-452.
    PubMed     Abstract available
    
    
    July 2021
60. DIAZ A, Dalmacy D, Hyer JM, Tsilimigras D, et al
    Intersection of social vulnerability and residential diversity: Postoperative outcomes following resection of lung and colon cancer.
    J Surg Oncol. 2021 Jul 1. doi: 10.1002/jso.26588.
    PubMed     Abstract available
    
    
    April 2021
61. JACOBSON FL, Dezube AR, Bravo-Iniguez C, Kucukak S, et al
    Preserving NLST mortality benefits and acceptable morbidity for lung cancer surgery in a community hospital.
    J Surg Oncol. 2021 Apr 12. doi: 10.1002/jso.26483.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.